TransMedics Group (TMDX) Tops Q1 EPS by 38c, raises outlook

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.35, $0.38 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $96.85 million versus the consensus estimate of $83.76 million.

Outlook:

TransMedics Group sees FY2024 revenue of $390-400 million, versus the consensus of $366.9 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
• Morgan Stanley upgrades CDW on stronger AI-driven server demand